The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
Open accessAbstract
Purpose: Recent advances in treatment of lung cancer require greater accuracy in the subclassification of non–small-cell lung cancer (NSCLC). Targeted therapies which inhibit tumor angiogenesis pose higher risk for adverse response in cases of squamous cell carcinoma. Interobserver variability and the lack of specific, standardized assays limit the current abilities to adequately stratify patients for such treatments. In this study, we set out to identify specific microRNA biomarkers for the identification of squamous cell carcinoma, and to use such markers for the development of a standardized assay. Patients and Methods: High-throughput microarray was used to measure microRNA expression levels in 122 adenocarcinoma and squamous NSCLC samples. A quantitative real-time polymerase chain reaction (qRT-PCR) platform was used to verify findings in an independent set of 20 NSCLC formalin-fixed, paraffin-embedded (FFPE) samples, and to develop a diagnostic assay using an additional set of 27 NSCLC FFPE samples. The assay was validated using an independent blinded cohort consisting of 79 NSCLC FFPE samples. Results: We identified hsa-miR-205 as a highly specific marker for squamous cell lung carcinoma. A microRNA-based qRT-PCR assay that measures expression of hsa-miR-205 reached sensitivity of 96% and specificity of 90% in the identification of squamous cell lung carcinomas in an independent blinded validation set. Conclusion: Hsa-miR-205 is a highly accurate marker for lung cancer of squamous histology. The standardized diagnostic assay presented here can provide highly accurate subclassification of NSCLC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
Pathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
Johnson, D. H., Fehrenbacher, L., Novotny, W. F., Herbst, R. S., Nemunaitis, J. J., Jablons, D. M., Langer, C. J., DeVore, R. F., Gaudreault, J., Damico, L. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.022 · Cited by 1,937
MicroRNA Signatures in Human Ovarian Cancer
Iorio, M. V., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C.-G., Alder, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1936 · Cited by 1,394
Serum MicroRNAs Are Promising Novel Biomarkers
Gilad, S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., Yerushalmi, N., Benjamin, H., Kushnir, M., Cholakh, H., Melamed, N., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003148 · Cited by 1,347
Self-citationMicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)
Zhu, S., Si, M.-L., Wu, H., & Mo, Y.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611393200 · Cited by 1,090
Extensive post-transcriptional regulation of microRNAs and its implications for cancer
Thomson, J. M., Newman, M., Parker, J. S., Morin-Kensicki, E. M., Wright, T., & Hammond, S. M. (2006) · Genes & Development · doi:10.1101/gad.1444406 · Cited by 877
MicroRNAs accurately identify cancer tissue origin
Rosenfeld, N., Aharonov, R., Meiri, E., Rosenwald, S., Spector, Y., Zepeniuk, M., Benjamin, H., Shabes, N., Tabak, S., Levy, A., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1392 · Cited by 812
Self-citationCummins, J. M., He, Y., Leary, R. J., Pagliarini, R., Diaz, L. A., Sjoblom, T., Barad, O., Bentwich, Z., Szafranska, A. E., Labourier, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511155103 · Cited by 744
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
Lu, Z., Liu, M., Stribinskis, V, Klinge, C. M., Ramos, K. S., Colburn, N. H., & Li, Y. (2008) · Oncogene · doi:10.1038/onc.2008.72 · Cited by 711
Micro-RNA profiling in kidney and bladder cancers
Gottardo, F., Liu, C. G., Ferracin, M., Calin, G. A., Fassan, M., Bassi, P., Sevignani, C., Byrne, D., Negrini, M., Pagano, F., et al. (2007) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.01.019 · Cited by 600
Marks, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90081-1 · Cited by 581
Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer
Sempere, L. F., Christensen, M., Silahtaroglu, A., Bak, M., Heath, C. V., Schwartz, G., Wells, W., Kauppinen, S., & Cole, C. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-5019 · Cited by 574
Xi, Y., Nakajima, G., Gavin, E., Morris, C. G., Kudo, K., Hayashi, K., & Ju, J. (2007) · RNA · doi:10.1261/rna.642907 · Cited by 567
Real-time expression profiling of microRNA precursors in human cancer cell lines
Jiang, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki863 · Cited by 501
Treatment of Non-small Cell Lung Cancer-Stage IIIA
Robinson, L. A., Ruckdeschel, J. C., Wagner, H., & Stevens, C. W. (2007) · Chest · doi:10.1378/chest.07-1379 · Cited by 457
MicroRNAs in Disease and Potential Therapeutic Applications
Soifer, H. S., Rossi, J. J., & Sætrom, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300311 · Cited by 394
MicroRNA expression profiles of esophageal cancer
Feber, A., Xi, L., Luketich, J. D., Pennathur, A., Landreneau, R. J., Wu, M., Swanson, S. J., Godfrey, T. E., & Litle, V. R. (2008) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.08.055 · Cited by 382
Li, J., Smyth, P., Flavin, R., Cahill, S., Denning, K., Aherne, S., Guenther, S. M., O'Leary, J. J., & Sheils, O. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-36 · Cited by 344
Self-citationMicroRNAs of the mammalian eye display distinct and overlapping tissue specificity.
Ryan, D. G., Oliveira-Fernandes, M., & Lavker, R. M. (2006) · PubMed · Cited by 305
MicroRNA expression profiles in head and neck cancer cell lines
Tran, N., McLean, T., Zhang, X., Zhao, C. J., Thomson, J. M., O’Brien, C., & Rose, B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.201 · Cited by 275
G�rtner, F., Schmitt, F. C., Preto, A., Reis-Filho, J. S., Simpson, P. T., & Martins, A. (2003) · Virchows Archiv · doi:10.1007/s00428-003-0859-2 · Cited by 235
A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells
Ibarra, I., Erlich, Y., Muthuswamy, S. K., Sachidanandam, R., & Hannon, G. J. (2007) · Genes & Development · doi:10.1101/gad.1616307 · Cited by 218
Nass, D., Rosenwald, S., Meiri, E., Gilad, S., Tabibian‐Keissar, H., Schlosberg, A., Kuker, H., Sion‐Vardy, N., Tobar, A., Kharenko, O., et al. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00184.x · Cited by 195
Self-citationp63 In pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors
Wang, B. Y., Gil, J., Kaufman, D., Gan, L., Kohtz, D. S., & Burstein, D. E. (2002) · Human Pathology · doi:10.1053/hupa.2002.126878 · Cited by 178
Treatment of Non-small Cell Lung Cancer, Stage IV
Socinski, M. A., Crowell, R., Hensing, T. E., Langer, C. J., Lilenbaum, R., Sandler, A. B., & Morris, D. (2007) · Chest · doi:10.1378/chest.07-1381 · Cited by 169
Sorafenib and Sunitinib in the Treatment of Advanced Non-Small Cell Lung Cancer
Gridelli, C., Maione, P., Gaizo, F. D., Colantuoni, G., Guerriero, C., Ferrara, C., Nicolella, D., Comunale, D., Vita, A. D., & Rossi, A. (2007) · The Oncologist · doi:10.1634/theoncologist.12-2-191 · Cited by 128
Field, R. W., Smith, B. J., Platz, C. E., Robinson, R. A., Neuberger, J. S., Brus, C. P., & Lynch, C. F. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh189 · Cited by 109
Stang, A., Pohlabeln, H., Müller, K. M., Jahn, I., Giersiepen, K., & Jöckel, K. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2005.11.012 · Cited by 84
Targeted therapies in lung cancer
Besse, B., Ropert, S., & Soria, J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm308 · Cited by 44
Cited by
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Iorio, M. V., & Croce, C. M. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100209 · Cited by 1,739
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Cancer Genome Atlas Research Network, Campbell, J. D., Alexandrov, A., Kim, J., Wala, J., Berger, A. H., Pedamallu, C. S., Shukla, S. A., Guo, G., Brooks, A. N., et al. (2016) · Nature Genetics · doi:10.1038/ng.3564 · Cited by 1,200
MicroRNAs in Cancer: Small Molecules With a Huge Impact
Iorio, M. V., & Croce, C. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.0317 · Cited by 959
microRNAs in cancer management
Kong, Y. W., Ferland-McCollough, D., Jackson, T. J., & Bushell, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70073-6 · Cited by 734
Boeri, M., Verri, C., Conte, D., Roz, L., Modena, P., Facchinetti, F., Calabrò, E., Croce, C. M., Pastorino, U., & Sozzi, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100048108 · Cited by 722
Metadata
- Authors
- Lebanony, D., Benjamin, H., Gilad, S., Ezagouri, M., Dov, A., Ashkenazi, K., Gefen, N., Izraeli, S., Rechavi, G., Pass, H., Nonaka, D., Li, J., Spector, Y., Rosenfeld, N., Chajut, A., Cohen, D., Aharonov, R., & Mansukhani, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-04-20
- Volume
- 27
- Issue
- 12
- Pages
- 2030-2037
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2171836441
- Cited by
- 408
- References
- 37
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.